Piramal's third quarter revenues up 9% but guidance pared
This article was originally published in Scrip
Executive Summary
Piramal Healthcare has reported a 9% increase in revenues to Rs9.1 billion ($201.4 million) for the third quarter ended December 31st, 2009, led by strong growth in the domestic formulations business. Net profit was up by 128% to Rs1.4 billion.